Gut–brain axis and brain health: modulating neuroinflammation, cognitive decline, and neurodegeneration
3 Biotech · 2025-01 · 15 (1)
DOI: 10.1007/s13205-024-04187-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift 3 Biotech, online erschienen am 27.12.2024. Verfasst von Anchal Trisal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences, Jamia Millia Islamia, New Delhi, 110025 India. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The microbiota-gut-brain axis is a pivotal medium of crosstalk between the central nervous system (CNS) and the gastrointestinal tract. It is an intricate network of synergistic molecular pathways that exert their effects far beyond their local vicinity and even affect the systemic functioning of the body. The current review explores the involvement of the gut-brain axis (GBA) in the functioning of the nervous system, with a special emphasis on the neurodegeneration, cognitive decline, and neuroinflammation that occur in Alzheimer's disease (AD) and Parkinson's disease (PD). Gut-derived microbial metabolites play an important role in facilitating this interaction. We also highlighted the complex interaction between gut-derived metabolites and CNS processes, demonstrating how microbial dysbiosis might result in clinical disorders. Short-chain fatty acids have neuroprotective properties, whereas branched-chain amino acids, trimethylamine-N-oxide (TMAO), and tryptophan derivatives such as indole have negative effects at high concentrations. Furthermore, we cover pharmaceutical and nonpharmacological approaches for restoring the gut microbial balance and promoting neurological health. We further expanded on nutritional therapies and lifestyle changes, such as the Mediterranean diet and exercise. Next, we focused on food-controlling habits such as caloric restriction and intermittent fasting. Moreover, interventional techniques such as prebiotics, probiotics, and pharmacological medications have also been utilized to modify the GBA. Historical microbiome research from early discoveries to recent studies linking gut health to cognitive and emotional well-being has increased our understanding of the GBA.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biosciences, Jamia Millia Islamia, New Delhi, 110025 India.
- Manipal Centre for Biotherapeutics Research, Manipal Academy of Higher Education, Karnataka Manipal, 576 104 India.
- Department of Zoology, Savitribai Phule Pune University, Pune, 411007 India.
- Amity University Uttar Pradesh, Noida, 212303 India.
ORCID-Profile: Abhishek Kumar Singh
Zitieren
APA
Trisal, A., Singh, I., Garg, G., Jorwal, K., & Singh, A. K. (2025). Gut–brain axis and brain health: modulating neuroinflammation, cognitive decline, and neurodegeneration. 3 Biotech, 15(1). https://doi.org/10.1007/s13205-024-04187-0
Vancouver
Trisal A, Singh I, Garg G, Jorwal K, Singh AK. Gut–brain axis and brain health: modulating neuroinflammation, cognitive decline, and neurodegeneration. 3 Biotech. 2025;15(1). doi:10.1007/s13205-024-04187-0
BibTeX
@article{Trisal2025,
author = {Trisal, Anchal and Singh, Ishika and Garg, Geetika and Jorwal, Khanak and Singh, Abhishek Kumar},
title = {Gut–brain axis and brain health: modulating neuroinflammation, cognitive decline, and neurodegeneration},
journal = {3 Biotech},
year = {2025},
volume = {15},
number = {1},
doi = {10.1007/s13205-024-04187-0}
}
EUVIMED